Common cutaneous manifestations and problems of diabetes mellitus.
D000666:Amphotericin B / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000150:complications; D005534:Foot Diseases / Q000209:etiology; D005947:Glucose / Q000378:metabolism; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects; D009761:Nystatin / Q000627:therapeutic use; D011711:Pyoderma / Q000209:etiology; D012871:Skin Diseases / Q000209:etiology*; D012877:Skin Manifestations; D012883:Skin Ulcer / Q000209:etiology; D014047:Tolnaftate / Q000627:therapeutic use; D014973:Xanthomatosis / Q000209:etiology
D014047:Tolnaftate; D009761:Nystatin; D006118:Griseofulvin; D000666:Amphotericin B; D005947:Glucose